Non-Current Assets
Other Non-Current Assets
Moderna Other Non-Current Assets increased by 11.6% to $675.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 21.4%, from $556.00M to $675.00M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Assets shows an upward trend with a 213.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ4 2017
Last reportedQ1 2026May 1, 2026
How to read this metric
Significant changes may indicate shifts in long-term operational strategy or changes in accounting for specific non-core assets.
Detailed definition
This captures miscellaneous long-term assets that do not fit into specific categories like property, plant, equipment, o...
Peer comparison
Varies widely by company; usually represents a small percentage of total assets.
Metric ID:
non_current_assets_other_assets_noncurrentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.00M | $4.00M | $46.00M | $82.00M | $75.00M | $38.00M | $988.00M | $1.16B | $1.29B | $661.00M | $766.00M | $650.00M | $641.00M | $556.00M | $594.00M | $556.00M | $546.00M | $530.00M | $605.00M | $675.00M |
| QoQ Change | — | +100.0% | >999% | +78.3% | -8.5% | -49.3% | >999% | +17.8% | +10.8% | -48.8% | +15.9% | -15.1% | -1.4% | -13.3% | +6.8% | -6.4% | -1.8% | -2.9% | +14.2% | +11.6% |
| YoY Change | — | — | — | — | >999% | +850.0% | >999% | >999% | >999% | >999% | -22.5% | -44.2% | -50.3% | -15.9% | -22.5% | -14.5% | -14.8% | -4.7% | +1.9% | +21.4% |
Range$2.00M – $1.29B
CAGR+240.6%
Avg YoY Growth+685.1%
Median YoY Growth-1.4%
Current Streak2 quarters growth
Other Non-Current Assets at Other Companies
Frequently Asked Questions
- What is Moderna's other non-current assets?
- Moderna (MRNA) reported other non-current assets of $675.00M in Q1 2026.
- How has Moderna's other non-current assets changed year-over-year?
- Moderna's other non-current assets increased by 21.4% year-over-year, from $556.00M to $675.00M.
- What is the long-term trend for Moderna's other non-current assets?
- Over 5 years (2020 to 2025), Moderna's other non-current assets has grown at a 213.4% compound annual growth rate (CAGR), from $2.00M to $605.00M.
- What does other non-current assets mean?
- Miscellaneous long-term assets that do not fall into standard reporting categories.